Propionic acidemia (PA) is a rare autosomal recessive disorder of metabolism caused by deficient activity of the mitochondrial enzyme propionyl-CoA carboxylase. The clinical manifestations are metabolic acidosis, poor feeding, lethargy, vomiting, osteoporosis, neurological dysfunction, pancytopenia, developmental retardation and cardiomyopathy. Liver transplantation has recently been considered as one of the treatment options for patients with PA. This case report describes several anesthetic considerations for patients with PA undergoing liver transplantation. Understanding the patient's status and avoiding events that may precipitate metabolic acidosis are important for anesthetic management of patients with PA. In conclusion, anesthesia should be focused on minimizing the severity of metabolic acidosis with following considerations: (1) maintaining optimal tissue perfusion by avoiding hypotension, (2) preventing hypoglycemia, and (3) providing bicarbonate to compensate for the acidosis. (Korean J Anesthesiol 2013; 65: 257-261) 
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Anesthesia for propionic acidemia treatment options for patients with PA to lower the risk of acute metabolic decompensation and to improve the quality of life [3] [4] [5] . This case report describes several anesthetic considerations for patients with PA undergoing LT.
Case Report
A 22-month old male (body weight: 12.6 kg, height: 90 cm) with PA was scheduled for living donor LT. He was a full term infant born to a family with a history of genetic disease in which his elder sister died of a metabolic disorder at an age of 45 days. He was diagnosed with PA at 7 days of age when he was present with poor feeding and lethargy. Urine amino acid analysis and plasma amino acid analysis were positive for glycine. Urine organic acid analysis was positive for methylcitric acid, propionylglycine, 3-hydroxypropionic acid and triglycine. Plasma organic acid analysis was positive for 3-hydroxypropionic acid and propionylgycine. Specific mutations were identified in the PCC beta polypeptide gene. After the diagnosis, his medical management included low protein diet to reduce the load on amino acid catabolism and administration of sodium benzoate, L-carnitine, L-arginine thiazolidine carboxylate and biotin. He had been hospitalized in many occasions due to pneumonia, metabolic acidosis, and poor oral intake. One month prior to LDLT, he was admitted several times for decreased activity, altered mental status, hyperammonemia and ketoacidosis.
Preoperative vital signs showed blood pressure of 100/47 mmHg, a heart rate of 104 beats/min, and a respiratory rate of 24 breaths/min. Preoperative laboratory results were as follows: white blood cell 4. Table 1 . The patient's postoperative course was complicated by persistent metabolic acidosis and hepatic failure due to hepatic vein obstruction (Table 2) . On postoperative day (POD) 0, dopamine 20 μg/kg/min was continuously infused due to low BP and aliquots of bicarbonate 20 mEq were administered to correct metabolic acidosis. On POD 1, abdominal sonography revealed hepatic vein obstruction prompting the patient to undergo emergency re-operation for hepatic vein obstruction. Anesthesia was induced and maintained with isoflurane in air and oxygen (inspiratory oxygen fraction of 0.5) and vecuronium. Ventilation was controlled with a tidal volume of 7-10 ml/kg and ventilatory rate was adjusted to maintain an end tidal CO 2 of 35-40 mmHg. After the induction, initial ABGA showed pH 7.135, BE -14.8mEq/L and a glucose level of 55 mg/dl. The patient received 5% dextrose 30 cc/hr and 0.45% normal saline 60 cc/hr. Dopamine 30 μg/kg/min was administered to maintain the mean BP above (55 mmHg) and continuous infusion of bicarbonate 8 mEq/hr was given for progressive metabolic acidosis. The surgery lasted for 2 hours, and the patient's ABGA at the end of surgery showed pH 7.179, BE -13.4 mEq/L and the glucose level of 55 mg/dl. In spite of re-operation, patient's liver function deteriorated further and metabolic acidosis worsened. Moreover, the patient developed hemodynamic compromise requiring continuous infusion of dopamine 30 μg/kg/min, epinephrine 1 μg/kg/min, and norepinephrine 5 μg/kg/min. On POD 4, the patient expired as a result of hepatic failure and subsequent severe metabolic acidosis.
Discussion
PA is an autosomal recessive inborn defect of metabolism caused by deficient activity of the mitochondrial enzyme PCC. Two distinct genotypic forms exist in mutations in either alpha or beta genes encoding for corresponding alpha-and betasubunits of PCC; however, there is no correlation between the genotypic forms and clinical severity. The prevalence of PA has been estimated in the Caucasian population to be 1 in 100,000 live births [1] , and in the Korean population, it has been estimated to be 1 in 81,128 live births by tandem mass screening in 2007 [6] . The clinical manifestations are initiated as early as several hours after birth with the start of dietary protein intake. The hallmark of this disorder is recurrent metabolic acidosis with ketosis and hyperlactatemia usual precipitation of by excessive protein ingestion or infection. Ketoacidosis results from inhibition of the citric acid cycle enzymes by propionic acid. In addition, other clinical signs and symptoms are poor feeding, lethargy, vomiting, osteoporosis, neurological dysfunction (seizure, hypotonia, and coma), pancytopenia, developmental retardation and cardiomyopathy [2] .
The management of PA includes primarily, dietary modifications with a low protein diet, along with metronidazole to reduce propionic acid-producing gut species and L-carnitine to promote propionic acid renal clearance. For acute management of acidosis and hyperammonemia, hydration with intravenous fluid containing dextrose and bicarbonate should be initiated promptly with concomitant treatment of precipitating events such as infection [7, 8] . Despite the improvement in conservative management, patients with PA are prone to relapsing episodes of metabolic acidosis mandating frequent hospital admissions, and thus, the overall outcome of PA remains disappointing [9] .
LT has been viewed as one of the potential treatment POD: postoperative day, HR: heat rate, BP: blood pressure (systolic/ mean/diastolic), CVP: central venous pressure, T. Bil: total bilirubin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ABGA: arterial blood gas analysis, BE: base excess.
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Anesthesia for propionic acidemia modalities for PA because liver is the major site of branched chain amino acid metabolism and subsequent propionic acid production. However, the role of LT in PA treatment is still controversial mostly due to the presence of extrahepatic sources (i.e., the gastrointestinal tract and the central nervous system) of propionic acid, and therefore, liver replacement offers only partial corrections of the metabolic defect. Early reports of LT for patients with PA showed unsatisfactory outcomes marked by significant mortality and transplantation-related complications [3, 10] . However, more recent studies suggested that LT has an important role in the management of PA in reducing the risk of metabolic decompensation and improving cardiomyopathy, neurocognitive dysfunction, and quality of life [4, 5, 11] . There fore, LT may have a key role in the course of PA treatment, as outcome of LT improve. In our case, the patient had a history of recurrent hospital admissions for poor oral intake, hyper ammonemia and altered mental status, and thus, LT was planned in order to improve the quality of life.
There are several anesthetic considerations for patients with PA. Preoperative evaluation of the patient should include acid balance, nutritional state, muscle tone, mental status and gastrointestinal function and cardiac functions. In particular, events such as hypoxia, dehydration, and hypotension, and the use of inappropriate anesthetics may precipitate and/or aggravate metabolic acidosis and must be avoided. During the preoperative fasting period, patients require glucose in their intravenous (IV) fluids to suppress protein catabolism and subsequent acidosis. In addition, lactic acid containing fluids should be avoided because it contributes to the patient's acid load and is also poorly metabolized by dysfunctional mitochondria. In our case, patient's IV fluids consisted of 5% DNK3 at 40 ml/hr, preoperatively. For general anesthesia, rapid sequence induction should be considered in patients experiencing reflux or vomiting. Moreover, anesthesiologists should be aware of anesthetic medications that are metabolized to propionic acid, odd chain organic acids, odd chain alcohol, acrylic acid, and odd chain fatty acids. These drugs are as follows: muscle relaxants including succinylcholine, atracurium, cistatracurium, and mivacurium [12] , propofol containing soybean oil rich in polyunsaturated fats [13] ; and analgesics including ibuprofen, naproxen, and ketoprofen [14] . These drugs are likely to initiate problem in patient with PA and should be avoided. Therefore, in our case, thiopental, rocuronium and vecuronium were used as anesthetic agents.
For prolonged surgery such as LT, serial monitoring of arterial pH and blood glucose is strongly advised in order to make rapid adjustments in metabolic derangements. Accordingly, in our patient, ABGA was performed hourly during the operation. Based on the ABGA findings, dextrose and bicarbonate were administered as needed. During LT, albumin is commonly administered because LT recipients usually have preexisting low serum albumin levels. However, albumin should be avoided in PA patients since protein restriction is an important part of the treatment protocol [5, 8] . Accordingly, in our patient, albumin was not used intraoperatively. During the postoperative period, patients with PA are at a high risk to develop respiratory distress secondary to fatigue or hypotonia and are prone to develop upper airway obstruction. Therefore, tracheal extubation should be delayed until patients regain adequate muscle strength. Additionally, humidified oxygen should be given to these patients [15] . Despite these anesthetic considerations, our patient expired on POD 4 mainly due to hepatic failure caused by hepatic vein obstruction.
In conclusion, understanding the patient's status and avoiding events that precipitate metabolic acidosis are important for anesthetic management for patients with PA undergoing LT. The mainstay of anesthesia should be focused on minimizing the severity of metabolic acidosis with following consierations: (1) maintaining optimal tissue perfusion by avoiding hypotension, (2) preventing hypoglycemia, and (3) providing bicarbonate to compensate for the acidosis.
